Evolution Group PLC
30 September 2003
THE EVOLUTION GROUP PLC
The Evolution Group Plc ("the Company") announces that David Norwood, the chief
executive of IP2IPO Group Plc ("IP2IPO"), has today sold 1,250,000 ordinary
shares of 1p each in the capital of the Company (representing 0.51 per cent of
the Company's issued share capital) at 80p per share. Following such sale Mr
Norwood retains 3,080,995 ordinary shares of 1p each in the capital of Evolution
(representing 1.25 per cent of the Company's issued share capital). Mr Norwood
is a non-executive director of Evolution.
It was announced this morning that it is proposed that the ordinary shares in
IP2IPO, the intellectual property commercialisation business in which Evolution
currently holds a 75.2% interest, be admitted to trading on the Alternative
Investment Market of the London Stock Exchange Plc and that IP2IPO is seeking to
raise £25 million net by way of a placing. Mr Norwood has indicated that it is
his intention to apply all of the proceeds of sale of ordinary shares in the
Company in subscribing £1 million for ordinary shares in IP2IPO as part of
IP2IPO's placing.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.